Delcath Systems (DCTH) Return on Capital Employed (2011 - 2026)
Delcath Systems' (DCTH) quarterly Return on Capital Employed came in at 1.43% in Q1 2026, up 52.0% year-on-year from 0.94% in Q1 2025, and down 344.17% quarter-over-quarter from 0.58% in Q4 2025.
Delcath Systems (DCTH) Return on Capital Employed (2011 - 2026) Analysis & Trends
Delcath Systems' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 1.43% for Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 52.0% year-over-year to 1.43% in Q1 2026; TTM through Mar 2026 was 1.43%, a 52.0% increase from a year earlier, with the FY2025 full-year figure at 0.74%, up 2486.0% from the prior year.
- Return on Capital Employed eased to 1.43% in Q1 2026 per DCTH's latest filing, from 0.58% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 5.47% in Q2 2025 and bottomed at 785.66% in Q4 2022.
- The 5-year median for Return on Capital Employed is 158.71% (2024), against an average of 180.87%.
- Across the five-year window, Return on Capital Employed plunged 69748 bps in 2022 and surged 64237 bps in 2023, its largest moves.
- Year by year, Return on Capital Employed stood at 785.66% in 2022, then soared by 82 bps to 143.29% in 2023, then surged by 82 bps to 25.86% in 2024, then surged by 102 bps to 0.58% in 2025, then tumbled by 344 bps to 1.43% in 2026.
- Per Business Quant, the three latest DCTH Return on Capital Employed figures stand at 1.43% (Q1 2026), 0.58% (Q4 2025), and 5.23% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Delcath Systems | 16,569.19 | -89.28 Mn | 21.26 Mn | -1.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.43% |
| Dec 31, 2025 | 0.58% |
| Sep 30, 2025 | 5.23% |
| Jun 30, 2025 | 5.47% |
| Mar 31, 2025 | -1.94% |
| Dec 31, 2024 | -25.86% |
| Sep 30, 2024 | -238.59% |
| Jun 30, 2024 | -158.71% |
| Mar 31, 2024 | -167.12% |
| Dec 31, 2023 | -143.29% |
| Sep 30, 2023 | -170.77% |
| Jun 30, 2023 | -219.91% |
| Mar 31, 2023 | -312.76% |
| Dec 31, 2022 | -785.66% |
| Sep 30, 2022 | -494.45% |
| Jun 30, 2022 | -244.39% |
| Mar 31, 2022 | -121.27% |
| Dec 31, 2021 | -88.18% |
| Sep 30, 2021 | -110.46% |
| Jun 30, 2021 | -109.89% |